Riskpilot← Back to searchSign inGet full accessNärke Röntgen AB
ABActiveOrg 5565801890Ekängsgatan 2Medical specialists activities · NACE 8622Est. 19991 employees
Revenue 2025
SEK 1M
+27% vs 2024
EBITDA margin
92.8%
+35% vs 2024
Equity ratio
38.1%
Financial strength
Net profit 2025
SEK 279K
-54% vs 2024
| Revenue | SEK 1M | +27% |
| EBITDA | SEK 956K | +35% |
| Net profit | SEK 279K | -54% |
| Total assets | SEK 2,3M | +4% |
| Equity | SEK 894K | -23% |
| Employees | 1 | — |
Legal name
Närke Röntgen AB
Org number
5565801890
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
23 november 1999
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva medicinsk röntgendiagnostik och bentäthetsmätning samt äga och förvalta fast och lös egendom ävensom idka därmed förenlig verksamhet.
Address
Ekängsgatan 2
Phone
+46706686580
Email
nils.qvarner@qrsab.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 272 | 851 | 929 | 810 | 1 030 |
| Staff expenses | — | — | — | — | −34 |
| EBITDA | 216 | 801 | 844 | 710 | 956 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −211 |
| EBIT | 216 | 801 | 844 | 710 | 956 |
| Net financials | −2 506 | −561 | −166 | −1 171 | −230 |
| Profit before tax | −290 | 518 | 570 | 736 | 451 |
| Tax | −209 | −165 | −141 | −135 | 172 |
| Net profit | −499 | 353 | 429 | 601 | 279 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 773 | 1 367 | 1 866 | 2 250 | 2 345 |
| Equity | 132 | 485 | 864 | 1 165 | 894 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 377 | 618 | 512 | 440 | 531 |
| Total debt | 377 | 618 | 512 | 440 | 531 |
EBITDA margin
92.8%
This company
15.8%
Market median
+487% vs market
20212025
Equity ratio
38.1%
This company
38.2%
Market median
+0% vs market
20212025
Return on equity
31.2%
This company
18.4%
Market median
+70% vs market
20212025
Net profit margin
27.1%
This company
8.1%
Market median
+235% vs market
20212025
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20212025
Debt / equity
1.62×
This company
0.62×
Market median
-161% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Närke Röntgen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Erik Åkesson Qvarner | Chief Executive Officer | 0 companies |
| Ingela Elisabet Qvarner | Deputy Board Member | 0 companies |